4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-22-001208
Options or other derivatives
- Chief Scientific Officer acquired 60,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kalled Susan Chief Scientific Officer | 2022-02-17 | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | D | ||
Loading xslF345X03/ownership.xml…